Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]

Meta-analysis confirms benefits and safety of precision medicine

Prof Razelle Kurzrock - University of California, San Diego, USA

Meta-analysis confirms benefits and safety of precision medicine ( Prof Razelle Kurzrock - University of California, San Diego, USA )

SPECTAlung: improving clinical trial access for patients with thoracic tumours

Dr Jessica Menis and Dr Benjamin Besse

SPECTAlung: improving clinical trial access for patients with thoracic tumours ( Dr Jessica Menis and Dr Benjamin Besse )

Ibrutinib combined with bendamustine plus rituximab in previously treated CLL...

Dr Paula Cramer - University of Cologne, Köln, Germany

Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL ( Dr Paula Cramer - University of Cologne, Köln, Germany )

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA

Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )

TAT 2016: Targeted anticancer therapies

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA

TAT 2016: Targeted anticancer therapies ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )

EHA 2015 highlights

Peter Goodwin - ecancer reporter

EHA 2015 highlights ( Peter Goodwin - ecancer reporter )

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )

Biomarkers for childhood relapsed acute lymphoblastic leukaemia

Prof Anthony Moorman - Newcastle University, Newcastle, UK

Biomarkers for childhood relapsed acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )

Exciting update on the Repurposing Drugs in Oncology (ReDO) project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium

Exciting update on the Repurposing Drugs in Oncology (ReDO) project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )

Overview of innovation in Hodgkin's lymphoma

Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award

Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )

Applications of chimaeric antigen receptor T-cells in leukaemia

Dr Carl June - University of Pennsylvania, Philadelphia, USA

Applications of chimaeric antigen receptor T-cells in leukaemia ( Dr Carl June - University of Pennsylvania, Philadelphia, USA )

Immunoconjugates address unmet needs in Hodgkin's lymphoma patients

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands

Immunoconjugates address unmet needs in Hodgkin's lymphoma patients ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )

More from ecancer